August 05, 2020
Judges in two Florida federal courts have turned down bids to sanction Boehringer Ingelheim Pharmaceuticals Inc. over evidence it allegedly failed to preserve in suits over the anticoagulant Pradaxa, with both judges saying the company can't be sanctioned for actions taken by its predecessor.